AdvanceCOR GmbH logo

AdvanceCOR GmbH

AdvanceCor GmbH, a drug development company, researches, develops, and commercializes therapeutics and diagnostics for the personalized treatment of heart and vascular diseases. It offers Revacept, a human Fc fusion protein that prevents the local activation of platelets at sites of vascular injury; and anti-GPVI antibodies.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://advancecor.de
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Fraunhoferstr. 9aD-82152 Martinsried
Munich
Germany
Email
Contact Number
+49 89 2000 204-10

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/advancecor-gmbh” connections=”true” suffix=””]